Merchavia Holdings and Investments Ltd (TLV:MRHL)
Israel · Delayed Price · Currency is ILS · Price in ILA 176.50
-5.20 (-2.86%)
Apr 13, 2026, 5:24 PM IDT
TLV:MRHL Revenue
In the year 2025, Merchavia Holdings and Investments had annual revenue of 415.00K ILS with 248.74% growth. Merchavia Holdings and Investments had revenue of 29.00K in the half year ending June 30, 2025, a decrease of -97.20%.
Revenue
415.00K
Revenue Growth
-78.66%
P/S Ratio
89.32
Revenue / Employee
415.00K
Employees
1
Market Cap
37.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 415.00K | 296.00K | 248.74% |
| Dec 31, 2024 | 119.00K | -1.73M | -93.56% |
| Dec 31, 2023 | 1.85M | -2.31M | -55.59% |
| Dec 31, 2022 | 4.16M | -6.45M | -60.78% |
| Dec 31, 2021 | 10.61M | 3.18M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Together Pharma | 109.63M |
| Clal Biotechnology Industries | 11.55M |
| Identi Healthcare | 10.93M |
| Almeda Ventures Limited Partnership | 7.86M |